153 related articles for article (PubMed ID: 3102492)
1. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
Wun TC; Reich E
J Biol Chem; 1987 Mar; 262(8):3646-53. PubMed ID: 3102492
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
[TBL] [Abstract][Full Text] [Related]
3. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
Moroi M; Aoki N
J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
Chapman HA; Stone OL
Biochem J; 1985 Aug; 230(1):109-16. PubMed ID: 2932100
[TBL] [Abstract][Full Text] [Related]
6. Purification of epidermal plasminogen activator inhibitor.
Hibino T; Izaki S; Izaki M
FEBS Lett; 1986 Nov; 208(2):273-7. PubMed ID: 3096778
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
Declerck PJ; De Mol M; Alessi MC; Baudner S; Pâques EP; Preissner KT; Müller-Berghaus G; Collen D
J Biol Chem; 1988 Oct; 263(30):15454-61. PubMed ID: 2459123
[TBL] [Abstract][Full Text] [Related]
8. Isolation of plasminogen activator inhibitor-2 (PAI-2) from human placenta. Evidence for vitronectin/PAI-2 complexes in human placenta extract.
Radtke KP; Wenz KH; Heimburger N
Biol Chem Hoppe Seyler; 1990 Dec; 371(12):1119-27. PubMed ID: 1708670
[TBL] [Abstract][Full Text] [Related]
9. Urokinase binds to a plasminogen activator inhibitor type-2-like molecule in placental microvillous membranes.
Jensen PH; Nykjaer A; Andreasen PA; Lund LR; Astedt B; Lecander I; Gliemann J
Biochim Biophys Acta; 1989 Nov; 986(1):135-40. PubMed ID: 2819091
[TBL] [Abstract][Full Text] [Related]
10. Platelet release protein which inhibits plasminogen activators.
Booth NA; Anderson JA; Bennett B
J Clin Pathol; 1985 Jul; 38(7):825-30. PubMed ID: 3926830
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of placental plasminogen activator (PPA).
Kobayashi T; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):783-92. PubMed ID: 3923141
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937.
Kruithof EK; Vassalli JD; Schleuning WD; Mattaliano RJ; Bachmann F
J Biol Chem; 1986 Aug; 261(24):11207-13. PubMed ID: 3090045
[TBL] [Abstract][Full Text] [Related]
13. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
Thorsen S; Philips M
Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
Hekman CM; Loskutoff DJ
Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.
Stump DC; Thienpont M; Collen D
J Biol Chem; 1986 Sep; 261(27):12759-66. PubMed ID: 3091604
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
Reilly TM; Seetharam R; Duke JL; Davis GL; Pierce SK; Walton HL; Kingsley D; Sisk WP
J Biol Chem; 1990 Jun; 265(16):9570-4. PubMed ID: 2188980
[TBL] [Abstract][Full Text] [Related]
17. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture.
Holmberg L; Lecander I; Persson B; Astedt B
Biochim Biophys Acta; 1978 Nov; 544(1):128-37. PubMed ID: 152655
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.
Booyse FM; Osikowicz G; Feder S; Scheinbuks J
J Biol Chem; 1984 Jun; 259(11):7198-205. PubMed ID: 6539333
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
Sudol M; Reich E
Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
[TBL] [Abstract][Full Text] [Related]
20. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
Wun TC; Palmier MO; Siegel NR; Smith CE
J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
